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Summary
Objective: Graft hypertrophy is a major complication seen in autologous chondrocyte implantation (ACI) with a periosteal ﬂap. We present the
ﬁrst magnetic resonance imaging (MRI) classiﬁcation for periosteal hypertrophy including a grading of clinical symptoms and the surgical
consequences.
Methods: One hundred and two patients with isolated chondral defects underwent an ACI covered with periosteum and were evaluated pre-
operatively, 6, 18 and 36 months after surgery. Exclusion criteria were meniscal pathologies, axial malpositioning and ligament instabilities.
Baseline clinical scores were compared with follow-up data by paired Wilcoxon-tests for the modiﬁed Cincinnati knee, the ICRS (International
Cartilage Repair Society) and a new MRI score including the parameters defect ﬁlling, subchondral edema, effusion, cartilage signal and graft
hypertrophy. Hypertrophic changes were graded from 1 (minimal) to 4 (severe).
Results: All scores showed signiﬁcant improvement (P< 0.001) over the entire study period. Patients with femoral lesions had signiﬁcantly bet-
ter results than patients with patella lesions after 18 and 36 months postoperative (P< 0.03). Periosteal hypertrophy occurred in 28% of all
patients. Fifty percent of all patella implants developed hypertrophic changes. No patient with grade 1, and all patients with grade 4 hypertrophy
had to undergo revision surgery. The Pearson correlation between graft hypertrophy and ICRS score was 0.78 after 6 months, and 0.69 after
36 months (P< 0.01). Inclusion of graft hypertrophy in the MRI score improves the correlation to clinical scores from 0.6 to 0.69.
Conclusions: Grading graft hypertrophy helps to identify patients needing an early shaving of the graft. Its integration into an MRI score im-
proves correlation with clinical scores. Re-operation depends on the grade of hypertrophy and clinical symptoms.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Hyaline cartilage has a limited capacity for intrinsic repair1e3.
Efﬁcacious treatment of chondral defects in the weight-
bearing zone of the knee remains a challenging therapeutic
problem4. To date, various articular cartilage-resurfacing
techniques have the potential to improve the repair of
cartilage defects and reduce the patient’s disability. From all
marrow stimulation techniques including microfracturing5e9,
abrasion chondroplasty10 and drilling11, the microfracture
procedure has the greatest potential to provide good clinical
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Received 19 September 2006; revision accepted 21 April 2007.133long-term results7e9. Clinical studies have shown a signiﬁ-
cant superiority of microfracturing, osteochondral transplan-
tation as well as autologous chondrocyte implantation (ACI)
over debridement in the treatment of full-thickness chondral
defects8,12e15. However, up today no surgical technique has
so far been able to produce normal hyaline cartilage. Further-
more, there has been no randomized controlled prospective
clinical trial that has proven signiﬁcantly better results of ACI
over mosaicplasty or microfracturing16,17. Knutsen et al.
were the ﬁrst investigators to compare the histological results
after microfracture and ACI in human beings. There was
a tendency for the ACI group to havemore hyaline repair car-
tilage than the group undergoing the microfracture proce-
dure, but this was not signiﬁcant with the low number of
patients available5. Osteochondral autografts require con-
verting a chondral into an osteochondral injury to effect artic-
ular repair14,15,18. This may affect the ultimate function of the9
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with persistent interface between the transplant and the sur-
rounding original cartilage19. In this context, Bentley et al.20
reported in a prospective randomized clinical trial of ACI vs
mosaicplasty a signiﬁcant superiority of ACI at 1 year, but
only in a post hoc subgroup analysis of participants with me-
dial condylar defects. The conclusions are still controversial
since other studies found equally good results with both sur-
gical techniques19,21.
Nevertheless ACI has been established as an effective
treatment for large chondral defects in the knee. Until now
good long-term results over 10 years have been described
only with the periosteum covered ACI which was introduced
by Peterson in 198722e25. The most common problem after
the classic ACI procedure is a periosteal hypertrophy de-
scribed as being up to 36% in the literature26e31. Until
now, no classiﬁcation has been available. The present
prospective study presents a novel magnetic resonance
imaging (MRI) classiﬁcation for periosteal hypertrophy
including a grading of clinical symptoms and the surgical
consequences.
Patients and methods
INCLUSION AND EXCLUSION CRITERIA
Between 1996 and 2000, a total of 102 patients (63 male
and 39 female) with isolated chondral lesions of the knee
underwent an ACI combined with a periosteal graft (Figs.
1 and 2). The average patient age was 34 (range 18e50)
years and average body mass index was 23.6 2.6 (range
18e30) kg/m2. All chondral defects were Outerbridge grade
3 or 4 lesions with an average size of 6.42 3.05 cm2
(range 3e16 cm2) (Table I).
Fig. 1. Chondral defect on the medial femoral condyle measuring
5 3.5 cm. The prepared lesion has a stable perpendicular edge
of healthy, well-attached viable cartilage surrounding the defect
providing a pool to hold the chondrocyte suspension within the
defect area.Excluded were patients with acute trauma, varus or val-
gus deformities with a malalignment over 5, limits in knee
extension or ﬂexion less than 130, patella-malalignment
with a medial or lateral shift of more than 0.5 cm, instabilities
of the collateral or cruciate ligaments, meniscal pathologies,
osteochondral defects, intra-articular corticosteroid injec-
tions within the previous month or knee arthroscopy within
the previous 6 months. Varus or valgus deformities could
be excluded by X-ray of the whole leg, and the correct
patella position was detected by a routine medio-lateral,
femoro-patellar and axial joint radiograph.
PATIENT EVALUATION AND SCORES
All patients were evaluated preoperatively and 6, 18 and
36 months postoperatively using two clinical and one MRI
scores: the modiﬁed Cincinnati score32, the ICRS scoring-
system33, and the Henderson MRI classiﬁcation with the fol-
lowing criteria: defect ﬁlling (1¼ complete; 2 50% of the
defect; 3< 50% and 4¼ full-thickness defect), cartilage sig-
nal (1¼ normal, i.e., identical to the adjacent articular carti-
lage; 2¼ nearly normal, i.e., slight areas of hyperintensity;
3¼ abnormal, i.e., larger areas of hyperintensity; and
4¼ absent), subchondral edema and effusion (both graded
as 1¼ absent; 2¼mild; 3¼moderate; and 4¼ severe)
[Figs. 3 and 4(a)]34. However hypertrophic changes of the
graft are not considered in this classiﬁcation. Thus we
added a ﬁfth criterium, namely ‘‘graft hypertrophy’’ [Table II;
Figs. 4(aee) and 5]. Additionally, we assigned an overall
MRI score, corresponding to the worst score in the ﬁve
categories. The details of the score are listed in Table II.
All MRIs were evaluated by two experienced radiologists.
MRI
All patients were investigated in a state of the art 1.5
T-MRI scanner (Sonata, Siemens, Erlangen, Germany),
Fig. 2. ACI with a periosteal cover. The ﬂap is sutured to the sur-
rounding rim of the prepared defect area to create a water-tight
chamber.
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Preoperative patient information: the parameters defect size, defect grade, body mass index and preoperative scores were not significantly
different between the three groups (P> 0.1, ManneWhitney U test). This makes the groups comparable
Group (1e3) Total 1: Femoral condyles 2: Trochlea 3: Patella
Number of patients 102 75 9 18
Gender (male:female) 63:39 53:22 5:4 5:13
Body mass index in kg/m2 (range) 23.6 2.6 (18e30) 23.7 2.5 (18e30) 23.8 2.1 (21e27) 23.3 3.2 (18e30)
Side (right:left) 58:44 46:29 4:5 8:10
Outerbridge classiﬁcation (range) 3.95 0.22 (3e4) 3.96 0.20 (3e4) 3.89 0.33 (3e4) 3.94 0.24 (3e4)
Defect size in cm2 (range) 6.42 3.05 (3e16) 6.57 2.98 (3e16) 6.7 4.1 (3e13) 5.7 2.8 (3e12)
Average age in years (range) 34.0 8.8 (18e50) 35.3 8.7 (18e50) 34.0 5.1 (28e42) 28.4 8.8 (18e43)
Preoperative scoring
1. ICRS score 3.78 0.41 3.81 0.39 3.67 0.5 3.72 0.46
2. Cincinnati score 3.58 0.49 3.56 0.49 3.56 0.53 3.67 0.49using a standard ﬂexible knee-coil and following MRI-
sequences:
T2-weighted fat-saturated (fs) coronal fast spin echo-
sequence (FSE) [repetition time (TR) 4540 ms, echo time
(TE) 26 ms, matrix 416 512 pixel).
T1-weighted spin-echo-sequence (SE) (TR 715 ms, TE
20 ms, matrix 416 512 pixel).
Proton-density-weighted sagittal SE-sequence (TR
2580 ms, TR 31 ms, matrix 636 768 pixel).
T2*-weighted fs sagittal gradient-echo-sequence (DESS
(dual echo at steady-state); TR 22.5 ms, TE 6.06 ms, ﬂip
angle 20, matrix 448 512 pixel). Field-of-view was
87 87 mm in all sequences. Slice thickness of all men-
tioned sequences was 3 mm with exception of the gradi-
ent-echo-sequence (1 mm). The duration of the whole
MRI-investigation was about 20 min.
Validity tests in the determination of knee-joint cartilage
thickness and hypertrophy by using MRI were performed by
the working group of Eckstein et al.35e37. In their investiga-
tions MRI was carried out at 1.5 T with 3D-Flash and 3D-
Dess sequences as used in our study protocol. Images
were performed in cadaveric knee-joint specimens andvolun-
teers. Following imaging, anatomical sections were obtained
at intervals of 2 mm with a diamond band saw. Cartilage
volumes and topographical thickness maps were obtained
and compared with those derived by image analysis. The
Fig. 3. Control arthroscopy 12 months after ACI in a 38-year-old
man. The defect is completely ﬁlled without any ﬁssures or signs
of hypertrophy.deviations of the MR volumes from those of the sections
were only 4.7% in the patella, 3.1% in the tibia plateau and
4.2% in the femur. The intraobserver and interobserver repro-
ducibilities were very high in both the specimens and the vol-
unteers, showing that the thicknessand volumesof knee-joint
cartilage may be accurately determined with MRI.
ACI
The ACI procedure was performed in two stages as de-
scribed by Peterson and Brittberg (Figs. 1 and 2)22,24,25.
Cell cultures were performed at Metreon Bioproduct
GmbH, a subsidiary of CellGenix Technology Transfer
GmbH, Freiburg, Germany. The periosteal graft was har-
vested from the proximal tibia38.
REHABILITATION
After the surgical procedure, the leg was enclosed in
a compressive bandage, rested, and elevated for 12 h to
avoid detachment of the membrane. After 12 h, continuous
passive motion was started for 6e8 h per day39.
Cold therapy was used for all patients for 1 week. Crutch-
assisted touchdown weight-bearing was performed for 6
weeks after the surgical procedure. Afterwards the patients
progressed to full weight-bearing and began a more vigor-
ous program of active motion of the knee. Crutch free walk-
ing was permitted after 3 months, and return to sports was
permitted after 4e6 months depending on the clinical
examination.
STATISTICAL ANALYSIS
Baseline clinical scores were compared with follow-up
data by paired Wilcoxon-tests and Friedman-tests for the
modiﬁed Cincinnati knee score32 and the ICRS score33.
Statistical comparison of different groups was performed
using the ManneWhitney U test for non-parametric
data40. Furthermore, MRI characteristics and clinical scores
were compared using the Pearson coefﬁcient of correlation.
All statistics were performed with SPSS (version 11.0) and
reviewed by an independent statistician. A P-value< 0.05
was considered statistically signiﬁcant.
Results
Seventy-ﬁve defects were located on the femoral con-
dyles (group 1), nine on the trochlea (group 2) and 18 on
the patella (group 3). There was no signiﬁcant difference
1342 P. C. Kreuz et al.: Classiﬁcation of graft hypertrophy after ACIFig. 4. Grading of graft hypertrophy: sagittal T2*-weighted, fat-suppressed gradient-echo-sequences of different grades of hypertrophy. The
area of ACI is marked in every MR image with a white arrow. The thickness of the tissue graft is marked with a white bar. As reference value
serves the thickness of the surrounding cartilage. It is marked with a white bar as well and set 100%. (a) No hypertrophy: the defect is com-
pletely ﬁlled without signs of subchondral edema and well integrated in the adjacent cartilage. (b) Grade 1 hypertrophy (125%): minimal hy-
pertrophic changes of the graft without any symptoms. (c) Grade 2 hypertrophy (150%): mild hypertrophy of 140% compared to the
surrounding articular cartilage. (d) Grade 3 hypertrophy (200%): moderate hypertrophy of 170% with symptoms of blocking and need for
arthroscopic trimming. (e) Grade 4 hypertrophy (>200%): the transplanted area shows a severe graft hypertrophy of 270% with patellar
pain and need for a surgical intervention.(P> 0.1) regarding defect size, defect grade, body mass
index and preoperative scores among the three groups
(Table I). This makes the groups comparable.
Before surgery all patients were evaluated ‘‘poor’’ or ‘‘fair’’
with the modiﬁed Cincinnati score and ‘‘abnormal’’ or ‘‘se-
verely abnormal’’ using the ICRS classiﬁcation system.
The scores improved signiﬁcantly in all three groups over
the entire study period, between preoperative and 6 months,
and between 6 and 18 months postoperative (P< 0.01). In
trochlear and retropatellar defects we noted no furtherimprovement between 18 and 36 months postoperative
(P> 0.1) (Table III). Signiﬁcantly better results were detected
in both scores after 18 and 36 months in femoral (1) com-
pared to retropatellar (3) defects (P< 0.03) (Table IV).
The Pearson coefﬁcient of correlation between both
scores (overall) was 0.7 after 6 months, 0.69 after 18
months, and 0.76 after 36 months. Regarding the entire
study period, the Cincinnati score rose by 1.66 and the
ICRS score by 1.59 points with no signiﬁcant difference be-
tween the two scores (Table III).Table II
MRI classification including the parameter graft hypertrophy. The overall MRI score corresponds to the worst score in the five categories
Defect ﬁlling Graft hypertrophy Cartilage signal Subchondral edema Effusion Overall MRI score
1¼Complete 1¼Minimal
(125%)
1¼Normal (identical to
adjacent cartilage)
1¼ Absent 1¼Absent 1¼ Excellent
2¼Good
3¼ Fair
4¼ Poor
2 50% of the
defect
2¼Mild
(150%)
2¼Nearly normal (slight areas
of hyperintensity)
2¼Mild 2¼Mild
3< 50% of the
defect
3¼Moderate
(200%)
3¼Abnormal (larger areas
of hyperintensity)
3¼Moderate 3¼Moderate
4¼ Full-thickness
defect
4¼Severe
(>200%)
4¼Absent 4¼ Severe 4¼Severe
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Control MRIs after 6 months revealed periosteal hypertro-
phy in 28% of all patients [Table V(a); Figs. 4(bee) and 5],
of whom only two were 40 years. Fifty percent of all pati-
ents with an ACI on the patella developed graft hypertrophy.
Scoring after 6 months revealed no clinical symptoms in
grade 1 hypertrophic changes [Fig. 4(b)]. There was no sig-
niﬁcant difference in the clinical scores between patients
with no and grade 1 hypertrophy (P> 0.05). However,
both clinical scores deteriorated from grade 1 to 4. A re-
operation was necessary in 50% (eight patients) of grade
3 periosteal hypertrophies [Table V(a) and Fig. 4(d)].
Thereof six cases could be controlled by arthroscopic shav-
ing. In two patients gaps were detected between the repar-
ative tissue and the surrounding cartilage. The hypertrophic
area was trimmed down with an arthroscopic rotatory blade
and microfracture was performed in the region without inte-
gration to the surrounding cartilage. In contrast to grade 3
Fig. 5. Control arthroscopy 6 months after ACI in a 33-year-old
man. The defect is ﬁlled with well integrated but extensive hypertro-
phic repair tissue responsible for clinical symptoms such as block-
ing, effusion and pain. The hypertrophic area was trimmed down
with a shaver to the level of the surrounding cartilage.hypertrophic changes surgical intervention was necessary
in 100% (four patients) of grade 4 periosteal hypertrophies
[Table V(a) and Fig. 4(e)]. In two patients the reparative tis-
sue could be controlled by arthroscopic shaving. In two
other patients the newly formed tissue was soft and im-
pressible with ﬁssures and missing integration. Therefore
we decided to perform a second ACI. Overall 28% of all pa-
tients with hypertrophic changes had to undergo surgery
again. After 36 months grade 3 and 4 changes were no
longer detectable (Table V(b)). No patient with grade 1 or
grade 2 hypertrophy had to undergo a further surgical inter-
vention. After 36 months the ICRS and Cincinnati score
had increased signiﬁcantly more in all patients without re-
operation (2.17 0.66/1.87 0.66 points) compared to
2.5 0.76/2.38 0.92 points in the eight patients that
were re-operated for graft hypertrophy in the ﬁrst year after
ACI (P¼ 0.048).
All ﬁve MRI parameters and the overall MRI score im-
proved signiﬁcantly from 6 to 36 months postoperative
(P< 0.05) (Table VI). Patients< 40 years showed signiﬁ-
cantly better results than patients 40 years (P< 0.01).
The Pearson correlation between clinical scores and the
parameter defect ﬁlling (without grading graft hypertrophy)
was only 0.39, as opposed to 0.65 with a 2-parameter
MRI score including graft hypertrophy and defect ﬁlling
(Table VII).
Furthermore, the correlation between clinical scores and
our 5-parameter MRI score (Table II) is 0.69 6 months after
surgery compared to 0.6 with a 4-parameter MRI score
without graft hypertrophy. No further difference was detect-
able after 36 months (Table VII).
Discussion
Periosteum is able to promote cartilage formation in
a chondrotrophic environment41,42. Free periosteal grafts
transplanted to chondrectomized articular surfaces of differ-
ent joints in experimental animals differentiated into amixture
of ﬁbrous tissue and ﬁbrocartilage43e46. This chondrogenic
potential arises because the cambium layer of periosteum
contains growth factors and chondrocyte precursor cells
that form cartilage during limb development, and does so
once again during fracture healing or periosteum transplan-
tation. The regenerative capacity is determined by surgical
factors such as orientation of the cambium layer, postopera-
tive factors such as the use of continuous passive motion,
and the age and maturity of the experimental animal41,42.Table III
ICRS and Cincinnati scores preoperative and 6,18 and 36 months after ACI in different defect locations (1e3). The scores improved signif-
icantly in all three groups (P< 0.05) over the entire study period, between preoperative and 6 months and between 6 and 18 months post-
operative. There was no more improvement in trochlear (2) and retropatellar (3) defects between 18 and 36 months postoperative (P> 0.1)
Group 1 2 3 Overall
Average ICRS score
Preoperative 3.81 0.39 3.67 0.5 3.72 0.46 3.78 0.41
After 6 months 2.81 0.67 2.89 0.6 2.83 0.62 2.82 0.65
After 18 months 2.24 0.61 2.44 0.53 2.56 0.51 2.31 0.59
After 36 months 2.12 0.67 2.22 0.67 2.5 0.62 2.19 0.67
Average Cincinnati score
Preoperative 3.56 0.49 3.56 0.53 3.67 0.49 3.58 0.49
After 6 months 2.4 0.64 2.44 0.53 2.56 0.51 2.43 0.61
After 18 months 1.91 0.64 2.11 0.78 2.22 0.65 1.99 0.65
After 36 months 1.84 0.68 2.0 0.71 2.22 0.65 1.92 0.68
Defect location e 1: femoral condyles; 2: trochlea; 3: retropatellar.
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Results on the defect location: listed is always the P-value (ManneWhitney U test for independent samples) between the scores of two
different defect locations. Significantly better results were detected after 18 and 36 months in femoral (1) compared to retropatellar (3) defects
in both scores (*P< 0.03)
Time after ACT 6 Months postoperative 18 Months postoperative 36 Months postoperative
Score ICRS Cincinnati ICRS Cincinnati ICRS Cincinnati
Location 1e2 P¼ 0.7 P¼ 0.79 P¼ 0.27 P¼ 0.33 P¼ 0.59 P¼ 0.44
Location 1e3 P¼ 0.86 P¼ 0.26 *P¼ 0.027 *P¼ 0.013 *P¼ 0.019 *P¼ 0.017
Location 2e3 P¼ 0.86 P¼ 0.67 P¼ 0.67 P¼ 0.67 P¼ 0.28 P¼ 0.42
Defect location e 1: femoral condyles; 2: trochlea; 3: retropatellar. *ManneWhitney U test with P< 0.03.Hypertrophic changes are one of the most common adverse
events in ACI using a periosteal graft27,29,31,47. Biopsy spec-
imens have shown that the most superﬁcial layer of the re-
generative tissue is composed of ﬁbrocytes and sparse
matrix, which most likely represents incorporated metaplas-
tic periosteal remnants25. The role of growth factors such
as vascular endothelial growth factor (VEGF) in the develop-
ment of hypertrophic tissue formation is still unclear. How-
ever, animal studies have shown that periosteal cells in the
grafted tissue differentiate into chondrocytes to form carti-
lage48. Some chondrocytes are immunopositive for VEGF
expression. This process could play an important role not
only for hypertrophic changes but also for blood vessel inva-
sion and endochondral ossiﬁcation, which can be seen
sometimes on the base of the repair tissue48. However, the
present study revealed no correlation between graft hyper-
trophy and periosteum taken from macroscopically well-
vascularized areas (Fig. 2). Furthermore, we tried to prepare
the periosteal patch as thin as possible removing all attached
adipose tissue to reduce all factors that might inﬂuence or
stimulate tissue hypertrophy.
Scoring after 6 months revealed no clinical symptoms in
grade 1 hypertrophic changes [Fig. 4(b)]. There was no sig-
niﬁcant difference in the scores of patients with no and
grade 1 hypertrophy (P> 0.05). Therefore we gave 1 pointto patients with grade 1 hypertrophy in the MRI score, the
same score-value as in patients with complete defect ﬁlling.
A surgical intervention was necessary in 50% of grade 3
[Fig. 4(d)], and in 100% of grade 4 [Fig. 4(e)] periosteal hy-
pertrophies. Grade 3 and 4 changes were no longer detect-
able after 36 months and the number of patients with grade
2 hypertrophies had fallen from 11 to 5. This means that
minimal grade 1 and 2 hypertrophic changes may diminish
over the time without surgical intervention. That is probably
a result of compression and tissue remodeling during nor-
mal joint motion and weight bearing. However, we observed
that hypertrophic changes >200% were always associated
with severe clinical symptoms (P< 0.001) and need for
a surgical intervention [Figs. 4(e) and 5]. The incidence of
graft hypertrophy after ACI was as follows in our study pop-
ulation: 50% on the patella, 25.3% on the femoral condyles,
and 11.1% on the trochlea. Others have reported that patel-
lar lesions do not fare as well as condylar lesions22, thus at-
tention to correction of patellofemoral maltracking has been
emphasized as a means of improving outcome25. Since
maltracking was excluded in our study population, we pos-
tulate that there is another explanation for patellar lesions’
worse results. Six of the nine treated patellar chondral
defects were located on the medial patellar facet. However,
this area has often no direct contact to the opposite trochleaTable V
Grading of periosteal hypertrophy 6 (a) and 36 (b) months postoperative: 29 of all patients showed hypertrophic changes after 6 months. Only
two of them were 40 years. Fifty percent of all patients with an ACI on the patella developed a graft hypertrophy. Scores after 6 months
revealed no clinical symptoms in grade 1 hypertrophic changes. A surgical intervention was necessary in 50% of grade 3 and in 100% of grade
4 periosteal hypertrophies. After 36 months grade 3 and 4 changes were no longer detectable
Grade of graft hypertrophy Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Overall
hypertrophy
(grade 1e4)
(a) MRI 6 months after surgery
Deﬁnition No hypertrophy 100e125% 125e150% 150e200% >200% >100%
Number of patients 73 (71.6%) 6 (5.9%) 11 (10.8%) 8 (7.8%) 4 (3.9%) 29 (28.4%)
Age
<40 Years 45 6 11 7 3 27
40 Years 28 0 0 1 1 2
Location
Femoral
Condyles 56 5 7 4 3 19
Trochlea 8 0 0 1 0 1
Retropatellar 9 1 4 3 1 9
Average ICRS score 2.37 0.49 2.0 0 3.0 0 3.25 0.46 3.5 0.58 2.93 0.59
Average Cincinnati score 2.08 0.49 2.0 0 2.18 0.4 2.75 0.46 3.0 0 2.41 0.5
Surgical intervention
for hypertrophy
0 0 0 4 (50%) 4 (100%) 8 (27.6%)
(b) MRI 36 months after surgery
Number of patients 91 (89.2%) 6 (5.9%) 5 (4.9%) 0 (0%) 0 (0%) 11 (10.8%)
Average ICRS score 1.91 0.5 2.43 0.53 3.0 0 0 0 2.64 0.5
Average Cincinnati score 1.65 0.48 2.0 0 2.75 0.5 0 0 2.27 0.47
1345Osteoarthritis and Cartilage Vol. 15, No. 12Table VI
MRI 6 and 36 months postoperative: all MRI parameters and the overall MRI score improved significantly from 6 to 36 months postoperative
(P< 0.05). The ManneWhitney U test revealed in all parameters significantly better results in patients< 40 years compared to patients 40
years (P< 0.01)
MRI parameter Defect ﬁlling Graft
hypertrophy
Cartilage
signal
Subchondral
edema
Effusion Overall MRI score
(with hypertrophy
classiﬁcation)
6 Months after surgery
Overall 1.62 0.72 2.34 0.97 1.81 0.59 2.18 0.62 1.45 0.56 2.41 0.68
Age< 40 years 1.29 0.5 2.26 0.94 1.6 0.56 1.9 0.61 1.4 0.5 2.27 0.74
Age 40 years 2.14 0.71 3.5 0.71 2.17 0.59 2.53 0.63 1.57 0.62 2.7 0.65
36 Months after surgery
Overall 1.23 0.49 1.36 0.5 1.33 0.51 1.31 0.51 1.17 0.4 1.34 0.54
Age< 40 years 1.1 0.33 1.3 0.48 1.1 0.31 1.1 0.31 1.1 0.18 1.13 0.35
Age 40 years 1.52 0.69 2.0 0.0 1.73 0.58 1.7 0.6 1.37 0.56 1.73 0.64which should give a kind of containment for the transplanted
area. This missing contact to the trochlea could be a reason
for the unhampered growth of the periosteal graft after
ACI on the medial patellar facet. The high number of pa-
tients with hypertrophic changes on the patella may have
led to the signiﬁcantly better results of femoral (1) compared
to patellar (3) lesions after 18 and 36 months (P< 0.03)
(Table IV).
Twenty-seven of all 29 patients with hypertrophic changes
were aged< 40 years. The low incidence of graft hypertro-
phy in older patients may be due to a diminished proliferative
capacity of the periosteal ﬂap’s cambium layer. Animal stud-
ies have shown that the chondrogenic potential of perios-
teum decreases with age41,42,49. The reduced regenerative
capacity of chondrocytes could be a reason for the worse re-
sults of patients over 40 years compared to younger patients.
Chondrocyte senescence is associated with a decline in mi-
tochondrial function, synthetic and mitotic activity and with
a decreased responsiveness to anabolic mechanical stimuli
and growth factors50,51. In this context, MRIs have shown
a signiﬁcantly worse defect ﬁlling in patients over 40 years.
Glaser and Putz52 have analyzed articular cartilage under
compressive loading by scanning-electron-microscopy.
They showed, that the removal of the upper tangential
zone was associated with increased overall superﬁcial tan-
gential strain and high peaks of surface tensile strain, leading
to ﬁssures. This could be an additional reason for the worse
results and the higher number of inhomogeneous cartilage
signals and subchondral edemas of patients over 40 years(Table VI). In the present study we did not ﬁnd a correlation
between graft hypertrophy and subchondral edema. In grade
4 hypertrophic changes [Figs. 4(e) and 5] a severe subchon-
dral edema was only detected in the two patients with a soft
and impressible newly formed tissue with missing integration
and need for a second ACI.
The importance of grading hypertrophy as part of an over-
all MRI score is obvious when one compares our MRI score
with and without the graft-hypertrophy parameter (Table VII).
When hypertrophic changes are disregarded, the Pearson
correlation between clinical scores and defect ﬁlling is signi-
ﬁcantly reduced. Moreover, the correlation between clinical
scores after 6months and the overall MRI score not including
the graft-hypertrophy parameter is worse (P< 0.05) than
the overall MRI score including hypertrophic changes
(Table VII). After 36months, the Pearson correlation showed
no more difference between the MRI score with and without
grading hypertrophy (Table VII). This may be explained by
the decline in hypertrophic changes from 28.4% after 6
months to 10.8% after 36 months, and the shift of patients
with grade 3 and 4 to grade 0, 1 and 2 changes.
This study demonstrates that grading periosteal hypertro-
phy makes good clinical sense and should be incorporated
into an overall MRI score for better correlation with clinical
scores. Furthermore, grading identiﬁes patients needing
early arthroscopic shaving of the graft to avoid increased
shear-stresses with risk of ﬁssures and graft failure. Re-
operation depends on the grade of hypertrophy and clinical
symptoms.Table VII
Pearson correlation between MRI and clinical scores: the parameters defect filling, graft hypertrophy, and cartilage signal correlated best with
clinical scores after 6 and 36 months. The Pearson coefficient of correlation between clinical and MRI scores remained always 0.67 and was
significant at the 0.01 level. The table compares the results of an MRI score with (*) and without (**) grading hypertrophy. Without grading
hypertrophy, the Pearson correlation between clinical scores and defect filling drops to 0.39. Furthermore, the correlation between clinical
scores and overall MRI score without grading hypertrophy is only 0.6, compared to 0.69 with an MRI score including hypertrophic changes
Defect ﬁlling Graft hypertrophy Subchondral edema Cartilage signal Effusion Overall MRI score
ICRS score, 6 months 0.77 (*) 0.78 0.52 0.81 0.61 0.69 (*)
0.35 (**) 0.6 (**)
Cincinnati score, 6 months 0.67 (*) 0.72 0.56 0.56 0.48 0.69 (*)
0.39 (**) 0.6 (**)
ICRS score, 36 months 0.65 (*) 0.69 0.66 0.70 0.61 0.69 (*)
0.32 (**) 0.69 (**)
Cincinnati score, 36 months 0.65 (*) 0.67 0.65 0.70 0.59 0.67 (*)
0.39 (**) 0.67 (**)
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